Published in J Neurooncol on September 01, 2003
Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol (2011) 1.40
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res (2014) 1.35
ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol (2014) 1.18
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med (2011) 1.14
Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med (2006) 1.14
The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res (2012) 1.05
The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer Cell Int (2006) 1.05
A new dimension of FDG-PET interpretation: assessment of tumor biology. Eur J Nucl Med Mol Imaging (2011) 1.04
Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol (2006) 1.04
Regulation and function of aquaporin-1 in glioma cells. Neoplasia (2007) 1.01
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Eur J Nucl Med Mol Imaging (2012) 0.99
Stem cell transplantation in brain tumors: a new field for molecular imaging? Mol Med (2010) 0.99
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response. Front Neurol (2015) 0.97
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro Oncol (2012) 0.94
¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging (2012) 0.92
Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med (2015) 0.90
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging (2008) 0.85
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging (2009) 0.85
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging (2010) 0.85
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging (2006) 0.84
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns. ScientificWorldJournal (2013) 0.82
Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med (2013) 0.81
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI. J Neurooncol (2012) 0.80
Usefulness of FMISO-PET for glioma analysis. Neurol Med Chir (Tokyo) (2013) 0.80
Imaging biomarkers in primary brain tumours. Eur J Nucl Med Mol Imaging (2014) 0.80
Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine. Arch Med Sci (2012) 0.80
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging. J Nucl Med (2015) 0.80
Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer. Nucl Med Mol Imaging (2015) 0.79
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol. Invest New Drugs (2009) 0.78
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS). J Neural Transm (Vienna) (2013) 0.78
Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol (2014) 0.78
Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II. J Mol Histol (2008) 0.78
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms. Br J Cancer (2006) 0.77
Correlation of (18)F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. J Nucl Med (2017) 0.77
Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients. Oncol Lett (2012) 0.75
Clinical Applications of PET and PET-CT. Med J Armed Forces India (2011) 0.75
Energy metabolism in neurodevelopment and medulloblastoma. Transl Pediatr (2015) 0.75
Usefulness of positron emission tomographic studies for gliomas. Neurol Med Chir (Tokyo) (2016) 0.75
Progressive multifocal exophytic pontine glioblastoma: a case report with literature review. Chin J Cancer (2017) 0.75
Applying metabolomics to understand the aggressive phenotype and identify novel therapeutic targets in glioblastoma. Metabolites (2014) 0.75
Emerging methods for disease monitoring in malignant gliomas. CNS Oncol (2013) 0.75
A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors. Indian J Nucl Med (2016) 0.75
Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review. Curr Neuropharmacol (2017) 0.75
PET/CT in paediatric malignancies - An update. Indian J Med Paediatr Oncol (2016) 0.75
Relationship of computed tomography perfusion and positron emission tomography to tumour progression in malignant glioma. J Med Radiat Sci (2014) 0.75
Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma. Br J Radiol (2010) 0.75
Neurologic Applications of PET/MR Imaging. Magn Reson Imaging Clin N Am (2017) 0.75
Sexual dimorphism in glioma glycolysis underlies sex differences in survival. JCI Insight (2017) 0.75
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (2005) 7.03
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis (1991) 6.69
Naturally occurring auxin transport regulators. Science (1988) 6.20
Basal localization of the presumptive auxin transport carrier in pea stem cells. Science (1983) 4.59
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol (1994) 4.37
Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill (2009) 4.23
Breast-milk substitutes--a South African perspective urgently needed. S Afr Med J (1995) 3.98
Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ (1997) 3.72
Child resistant containers needed for liquid medications. BMJ (1993) 3.42
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Differential interactions of promoter elements in stress responses of the Arabidopsis Adh gene. Plant Physiol (1994) 2.92
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity (1994) 2.90
THE UTILIZATION OF INTRAVENOUSLY INJECTED SALT IN NORMALS AND IN PATIENTS WITH CUSHING'S SYNDROME BEFORE AND AFTER ADMINISTRATION OF DESOXYCORTICOSTERONE ACETATE. J Clin Invest (1944) 2.64
Alkali cation selectivity of squid axon membrane. Ann N Y Acad Sci (1966) 2.40
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Low levels of zinc in hair, anorexia, poor growth, and hypogeusia in children. Pediatr Res (1972) 2.12
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology (2003) 2.10
Normal cervical dilatation pattern in late pregnancy and labor. Am J Obstet Gynecol (1970) 2.09
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol (1995) 2.05
The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg (2004) 2.05
The Escherichia coli biotin biosynthetic enzyme sequences predicted from the nucleotide sequence of the bio operon. J Biol Chem (1988) 2.00
MAGNESIUM PARTITION STUDIES IN GRAVES' DISEASE AND IN CLINICAL AND EXPERIMENTAL HYPOTHYROIDISM. J Clin Invest (1941) 1.89
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry (1997) 1.86
3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J (1998) 1.83
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol (1994) 1.80
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab (2000) 1.77
A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke (1995) 1.75
Conformation and molecular mechanisms of carriers and channels. Ann N Y Acad Sci (1975) 1.74
The health of caregivers for children with disabilities: caregiver perspectives. Child Care Health Dev (2007) 1.73
Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu Rev Immunol (1994) 1.73
Functional consequences of engagement of the T cell receptor by low affinity ligands. J Immunol (1993) 1.70
Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. Chem Biol (1996) 1.61
Cloning, sequencing and expression of subtilisin Carlsberg from Bacillus licheniformis. Nucleic Acids Res (1985) 1.61
Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature (1987) 1.60
Norwegian scabies and a toxic shock syndrome toxin 1-producing strain of Staphylococcus aureus endocarditis in a patient with trisomy 21. Clin Infect Dis (1998) 1.60
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab (2000) 1.56
[Transanal endoscopic surgery of the rectum - testing a new method in animal experiments]. Leber Magen Darm (1983) 1.56
Improved ejection fraction and flow velocity estimates with use of view sharing and uniform repetition time excitation with fast cardiac techniques. Radiology (1995) 1.54
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J Virol (1989) 1.49
Posterior lenticonus: clinical patterns and genetics. J Pediatr Ophthalmol Strabismus (1993) 1.49
Outcome of antenatally suspected congenital cystic adenomatoid malformation of the lung: 10 years' experience 1991-2001. Arch Dis Child Fetal Neonatal Ed (2005) 1.48
Tublin: nucleotide binding and enzymic activity. J Mol Biol (1974) 1.46
Is apoptosis present in progression to chronic hypertensive heart failure? J Card Fail (2000) 1.45
The impact of familial loading on gender differences in age at onset of schizophrenia. Acta Psychiatr Scand (1994) 1.44
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Am Coll Cardiol (1990) 1.42
Intracranial abnormalities requiring emergency treatment: identification by a single midline tomographic slice versus complete CT of the head. South Med J (1992) 1.39
Transformation of Aspergillus giganteus to hygromycin B resistance. Curr Genet (1990) 1.38
A novel human type II cytokeratin, K6hf, specifically expressed in the companion layer of the hair follicle. J Invest Dermatol (1998) 1.37
Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation (1987) 1.37
Airway obstruction by Ascaris, roundworm in a burned child. Burns (1999) 1.34
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci U S A (1990) 1.33
Isolation of the ornithine-delta-aminotransferase cDNA and effect of salt stress on its expression in Arabidopsis thaliana. Plant Physiol (1998) 1.31
Is laparoscopic surgery applicable to complicated colonic diverticular disease? Surg Endosc (1997) 1.27
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol (1996) 1.27
Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry (1995) 1.26
DNA-mediated genetic correction of thiamineless Arabidopsis thaliana. Nature (1974) 1.25
Polymorphism of alcohol dehydrogenase in Arabidopsis thaliana (L.) Heynh.: genetical and biochemical characterization. Biochem Genet (1984) 1.25
Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system. Gene Ther (1998) 1.21
Two Feedback-Insensitive Enzymes of the Aspartate Pathway in Nicotiana sylvestris. Plant Physiol (1992) 1.21
Identification of the flagellar proteins of Chlamydomonas reinhardii. Exp Cell Res (1970) 1.21
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J (2001) 1.20
World's best practice in tobacco control. Tob Control (2000) 1.19
Sequence analysis of two null-mutant alleles of the single Arabidopsis Adh locus. Mol Gen Genet (1990) 1.19
Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology (1979) 1.19
VIP-, enkephalin-, substance P- and somatostatin-like immunoreactivity in neurons intrinsic to the intestine: immunohistochemical evidence from organotypic tissue cultures. Brain Res (1978) 1.18
Duplex microtubule is a new form of tubulin assembly induced by polycations. Nature (1975) 1.18
Functional MRI statistical software packages: a comparative analysis. Hum Brain Mapp (1998) 1.14
Health and housing: a historical examination of alternative perspectives. Int J Health Serv (1981) 1.14
Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest (2000) 1.14
Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J Virol (1995) 1.11
Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2. J Virol (1992) 1.11
Sucrose synthase of Arabidopsis: genomic cloning and sequence characterization. Plant Mol Biol (1992) 1.10
Fate of exogenous DNA in Arabidopsis thaliana. Translocation and integration. Eur J Biochem (1971) 1.09
Sodium ions and the secretion of catecholamines. J Physiol (1969) 1.09
The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill (2011) 1.09
Country profile. South Africa. Lancet (1997) 1.08
Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia. Proc Natl Acad Sci U S A (1988) 1.08
Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther (1994) 1.07
Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma. Cancer Gene Ther (2006) 1.07
New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material. J Card Fail (1998) 1.07
Surface phenomena in lungs in health and disease. Medicine (Baltimore) (1965) 1.07
Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol (1981) 1.07
The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci (1997) 1.06
Peptide neurons in peripheral tissues including the urinary tract: immunohistochemical studies. Acta Pharmacol Toxicol (Copenh) (1978) 1.06
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. Synapse (1999) 1.05
Laparoscopic cholecystectomy in acute cholecystitis. J Laparoendosc Surg (1991) 1.05
The nature of flow in the systemic venous pathway measured by magnetic resonance blood tagging in patients having the Fontan operation. J Thorac Cardiovasc Surg (1997) 1.05
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation (2000) 1.05
In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. J Nucl Med (2000) 1.05
Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg (2001) 1.04
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif Organs (1998) 1.04
AIDS: animal retrovirus models and vaccines. J Acquir Immune Defic Syndr (1988) 1.04
Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension (1998) 1.03
Critical review of experience with surgical repair of coarctation of the aorta. J Thorac Cardiovasc Surg (1979) 1.03
A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1. J Virol (1996) 1.02
Microtubular protein reaction with nucleotides. Biochem Biophys Res Commun (1976) 1.02
Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther (1994) 1.01